BME MTF Equity Other Segments
0.11 mill. €
% Year 2018
Santiago de Torres
"We are a company that combines innovation with diagnosis and treatment".
ATRYS HEALTH D2018-ENERO
GVC GAESCO VALORES, S.V., S.A.
BDO AUDITORES, S.L.
CL/ VELAZQUEZ 24, 28001 MADRID
Capital Admitted (thousands of euros)
Shares (x 1,000)
Period Close Price (euros)
Period Last Price (euros)
Period High Price (euros)
Period Low Price (euros)
Capitalisation (thousands of euros)
Volume (thousands of shares)
Turnover (thousands of euros)
"ATRYS Health specializes in innovative medical diagnostic imaging.and personalized cancer diagnosis and treatments in advanced single-dose radiation therapy company. Our commitment to R & D puts us at the forefront of individualized medicine ."
ATRYS is an innovative company dedicated to providing diagnostic services and medical treatments of excellence, combining technical diagnostic accuracy in pathological and molecular and diagnostic anatomy online image through its own technological platform multi-specialty, with new radiation oncology treatments.
ATRYS aims to apply the most advanced methods of diagnosis and treatment of cancer. The commitment of the Company is to bring medical excellence as many potential patients, by applying the latest technology and the most advanced scientific knowledge.
The company also offers online services in different specialties medical imaging diagnosis, through its own platform, such as radiology, cardiology, ophthalmology and dermatology. These services allow relocate the report of the specialist center where the test is performed.
ATRYS carries out an integrated management of oncological disease, from individualized diagnosis (pathology, molecular, genetic and radiological) to the hypo-fractionated radiotherapy or single dose patients likely to benefit from this treatment, through collaborative arrangements management centers reference health.
The company, whose headquarter is located in Madrid, has two main laboratories, equipped with equipment and technologies needed for diagnosis and research, located in Barcelona and Granada Genyo Center.
Also, ATRYS develops projects of applied R & D that have generated several patent families, in collaboration with centers of national and international reference, aimed at improving diagnostic systems and treatment modalities, which allows the company to incorporate latest scientific advances to their clinical practice.
The ATRYS business model is based on four pillars:
Resumen Discovery MeetingATRYS HEALTHForo Medcap 2019
Resumen discovery meeting (Foro Medcap - Junio 2017)ATRYS HEALTH
Santiago de TorresPresidenteATRYS HEALTH
To obtain detailed information or information in other formats, please contact BME Market Data at
email@example.com or visit the website
The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties, it is required a prior and express permission from BME Market Data. Please contact us at firstname.lastname@example.org.
Follow us in
What is BME Growth
News and Publications
Copyright © BME 2020. All rights reserved.